Literature DB >> 18562617

Inducible cAMP early repressor acts as a negative regulator for kindling epileptogenesis and long-term fear memory.

Nobuhiko Kojima1, Gilyana Borlikova, Toshiro Sakamoto, Kazuyuki Yamada, Toshio Ikeda, Shigeyoshi Itohara, Hiroaki Niki, Shogo Endo.   

Abstract

Long-lasting neuronal plasticity as well as long-term memory (LTM) requires de novo synthesis of proteins through dynamic regulation of gene expression. cAMP-responsive element (CRE)-mediated gene transcription occurs in an activity-dependent manner and plays a pivotal role in neuronal plasticity and LTM in a variety of species. To study the physiological role of inducible cAMP early repressor (ICER), a CRE-mediated gene transcription repressor, in neuronal plasticity and LTM, we generated two types of ICER mutant mice: ICER-overexpressing (OE) mice and ICER-specific knock-out (KO) mice. Both ICER-OE and ICER-KO mice show no apparent abnormalities in their development and reproduction. A comprehensive battery of behavioral tests revealed no robust changes in locomotor activity, sensory and motor functions, and emotional responses in the mutant mice. However, long-term conditioned fear memory was attenuated in ICER-OE mice and enhanced in ICER-KO mice without concurrent changes in short-term fear memory. Furthermore, ICER-OE mice exhibited retardation of kindling development, whereas ICER-KO mice exhibited acceleration of kindling. These results strongly suggest that ICER negatively regulates the neuronal processes required for long-term fear memory and neuronal plasticity underlying kindling epileptogenesis, possibly through suppression of CRE-mediated gene transcription.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562617      PMCID: PMC6670907          DOI: 10.1523/JNEUROSCI.0412-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  21 in total

Review 1.  Is epilepsy a preventable disorder? New evidence from animal models.

Authors:  Kathryn A Giblin; Hal Blumenfeld
Journal:  Neuroscientist       Date:  2010-06       Impact factor: 7.519

Review 2.  Transcriptional Regulation Involved in Fear Memory Reconsolidation.

Authors:  Xu Wang; Min Li; Haitao Zhu; Yongju Yu; Yuanyuan Xu; Wenmo Zhang; Chen Bian
Journal:  J Mol Neurosci       Date:  2018-05-23       Impact factor: 3.444

Review 3.  PDE3 Inhibitors Repurposed as Treatments for Age-Related Cognitive Impairment.

Authors:  Shuichi Yanai; Shogo Endo
Journal:  Mol Neurobiol       Date:  2018-10-11       Impact factor: 5.590

4.  Decreased CREB levels suppress epilepsy.

Authors:  Xinjian Zhu; Xiao Han; Julie A Blendy; Brenda E Porter
Journal:  Neurobiol Dis       Date:  2011-08-10       Impact factor: 5.996

5.  Distinctive roles for amygdalar CREB in reconsolidation and extinction of fear memory.

Authors:  Natalie C Tronson; Shari L Wiseman; Rachael L Neve; Eric J Nestler; Peter Olausson; Jane R Taylor
Journal:  Learn Mem       Date:  2012-04-13       Impact factor: 2.460

Review 6.  Epileptogenesis.

Authors:  Asla Pitkänen; Katarzyna Lukasiuk; F Edward Dudek; Kevin J Staley
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-18       Impact factor: 6.915

7.  Cilostazol improves hippocampus-dependent long-term memory in mice.

Authors:  Shuichi Yanai; Yuki Semba; Hideki Ito; Shogo Endo
Journal:  Psychopharmacology (Berl)       Date:  2014-01-25       Impact factor: 4.530

8.  BDNF selectively regulates GABAA receptor transcription by activation of the JAK/STAT pathway.

Authors:  Ingrid V Lund; Yinghui Hu; YogendraSinh H Raol; Rebecca S Benham; Ramona Faris; Shelley J Russek; Amy R Brooks-Kayal
Journal:  Sci Signal       Date:  2008-10-14       Impact factor: 8.192

Review 9.  Molecular pathways controlling inhibitory receptor expression.

Authors:  Heidi L Grabenstatter; Shelley J Russek; Amy R Brooks-Kayal
Journal:  Epilepsia       Date:  2012-12       Impact factor: 5.864

Review 10.  Alteration of epileptogenesis genes.

Authors:  Amy R Brooks-Kayal; Yogendra H Raol; Shelley J Russek
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.